Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -196,122 | -82,123 | -269,476 | -189,033 | -103,913 |
| Depreciation Amortization | 8,794 | 4,346 | 15,625 | 11,430 | 7,414 |
| Income taxes - deferred | N/A | 8,751 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 87 | -354 | 1,058 | 2,144 | 663 |
| Other Working Capital | 3,190 | -10,807 | 7,542 | 13,130 | 1,056 |
| Other Operating Activity | 45,978 | 915 | -44,799 | -51,654 | -54,407 |
| Operating Cash Flow | $-138,073 | $-79,272 | $-290,050 | $-213,983 | $-149,187 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,753 | -2,176 | -20,876 | -16,274 | -11,924 |
| Purchase Of Investment | -71,267 | -20,431 | -78,688 | -63,583 | -45,961 |
| Sale Of Investment | 180,374 | 85,334 | 310,126 | 201,991 | 148,160 |
| Investing Cash Flow | $105,354 | $62,727 | $210,562 | $122,134 | $90,275 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 29,741 | 236 | 4,913 | 3,852 | 2,231 |
| Financing Cash Flow | $29,741 | $236 | $4,913 | $3,852 | $2,231 |
| Beginning Cash Position | 187,273 | 187,273 | 261,848 | 261,848 | 261,848 |
| End Cash Position | 184,295 | 170,964 | 187,273 | 173,851 | 205,167 |
| Net Cash Flow | $-2,978 | $-16,309 | $-74,575 | $-87,997 | $-56,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,073 | -79,272 | -290,050 | -213,983 | -149,187 |
| Capital Expenditure | -3,753 | -2,176 | -20,876 | -16,274 | -11,924 |
| Free Cash Flow | -141,826 | -81,448 | -310,926 | -230,257 | -161,111 |